Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Cabotegravir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,805Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Apretude

    02 7Cabenuva

    03 5Complera/Eviplera

    04 11Edurant

    05 5Juluca

    06 5Odefsey

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Juluca

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Juluca

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 686

    2019 Revenue in Millions : 507

    Growth (%) : 35

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Edurant

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Edurant

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Johnson & Johnson

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 964

    2019 Revenue in Millions : 861

    Growth (%) : 12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Complera/Eviplera

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Complera/Eviplera

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 269

    2019 Revenue in Millions : 406

    Growth (%) : -34

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Odefsey

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,672

    2019 Revenue in Millions : 1,655

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Juluca

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Juluca

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 700

    2020 Revenue in Millions : 678

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Cabenuva

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Cabenuva

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 51

    2020 Revenue in Millions : 0

    Growth (%) : New Launch in 2021

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Edurant

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Edurant

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Johnson & Johnson

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 994

    2020 Revenue in Millions : 964

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Cabenuva

    Cabotegravir

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Cabenuva

    United Kingdom
    arrow
    iPHEX India
    Not Confirmed

    GlaxoSmithKline

    Cabotegravir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 51

    2020 Revenue in Millions : 0

    Growth (%) : New Launch in 2021

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Odefsey

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Odefsey

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 1,568

    2020 Revenue in Millions : 1,672

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Complera/Eviplera

    Cabotegravir, Rilpivirine

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Complera/Eviplera

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Gilead

    Cabotegravir, Rilpivirine

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 258

    2020 Revenue in Millions : 269

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF